Location History:
- Oostakker, BE (2021)
- Zwijnaarde, BE (2020 - 2024)
Company Filing History:
Years Active: 2020-2025
Title: Beatrijs Strubbe: Innovator in Cancer Research
Introduction
Beatrijs Strubbe is a notable inventor based in Oostakker, Belgium. She has made significant contributions to the field of cancer research, particularly through her innovative work on polypeptides that target Wnt signaling pathways in tumor cells. With a total of four patents to her name, Strubbe's inventions are paving the way for new treatment methods for cancer.
Latest Patents
Strubbe's latest patents include groundbreaking inventions such as "Polypeptides antagonizing Wnt signaling in tumor cells." This invention provides LRP5-binding polypeptides, specifically LRP5-binding immunoglobulin single variable domain constructs that can inhibit Wnt signaling pathways. The invention also details specific sequences of these polypeptides, methods of their production, and their application in treating diseases like cancer. Another significant patent is "Biparatopic polypeptides antagonizing Wnt signaling in tumor cells." This invention introduces novel biparatopic LRP5/LRP6 cross-reactive binding polypeptides, which can also inhibit Wnt signaling pathways. It includes specific sequences, production methods, and treatment applications for cancer.
Career Highlights
Throughout her career, Beatrijs Strubbe has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Ablynx N.V. Her work in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in cancer treatment.
Collaborations
Strubbe has collaborated with esteemed colleagues such as Vittoria Zinzalla and Marie-Ange Buyse. These partnerships have fostered a collaborative environment that enhances the development of her inventions.
Conclusion
Beatrijs Strubbe's contributions to cancer research through her innovative patents highlight her role as a leading inventor in the field. Her work continues to inspire advancements in treatment methodologies for cancer patients.